TABLE 2:

Data in 25 patients treated with intra-arterial nimodipine for symptomatic cerebral vasospasm after SAH

Pt/No. of Tx	Indication for Angiography	Days after SAH	Symptom Onset after Spasm, h	Vessel with Spasm	Side	Spasm Severity	Vessel Infused	Nimodipine Dose per Session, mg	SAP Change, mm Hg	Angio-graphic Results	Clinical Results	GOS Score	Modified Rankin Score
1/1	Decreased LOC	6	18	tICA, MCA	R	Moderate	ICA R	1.0	0	Good	Improved	2	2
2/1	Decreased LOC	7	18	tICA, MCA, ACA	L	Severe	ICA L	1.0	−10	Excellent	Improved	1	1
3/1	Decreased LOC	6	24	tICA, MCA, ACA	R/L	Moderate	ICA R/L	3.0	−15	Poor	Unchanged	3	3
4/1	R hemiparesis	7	18	tICA, MCA, ACA	L	Moderate	ICA L	2.0	−10	Poor	Improved	1	0
5/1	L hemiparesis	8	24	ACA	R	Mild	ICA R	1.0	0	Good	Improved	2	2
6/2	L MCA > 200 cm/s	7	6	tICA, MCA, ACA	L	Severe	ICA L	2.0	−20	Poor	Unchanged
6^*	R hemiparesis	9	24	tICA, MCA, ACA	L	Severe	ICA L	3.0	−20	Good	Unchanged^*	3	3
7/1	Dysphasia	10	12	MCA	L	Mild	ICA L	3.0	−15	Poor	Improved	1	0
8/1	Disorientation	9	24	tICA, MCA, ACA	L	Severe	ICA L	2.0	−20	Poor	Improved	1	0
9/1	Decreased LOC	5	18	tICA, MCA	L	Moderate	ICA L	1.0	10	Good	Improved	3	3
10/1	R-leg monoparesis	15	18	ACA	L	Mild	ICA L	2.0	−15	Good	Improved	1	0
11/1	Decreased LOC	6	24	tICA, ACA	R	Moderate	ICA R	2.0	−30	Good	Improved	2	2
12/2	L hemiparesis	7	12	Diffuse	R/L	Severe	ICA R/L, VA L	3.0	−20	Poor	Unchanged
12^*	L hemiparesis	8	24	Diffuse	R/L	Severe	ICA R/L, VA L	5.0	−30	Good	Improved^*	5	6
13/1	Decreased LOC	4	12	tICA, MCA, ACA	R/L	Moderate	ICA R/L	3.0	−30	Poor	Unchanged	5	6
14/2	Cranial nerve III paresis	11	18	BA, PCA	R	Moderate	VA L	3.0	−20	Poor	Unchanged
14^*	Cranial nerve III paresis	12	24	BA, PCA	R	Moderate	VA L	2.0	−25	Poor	Improved^*	1	0
15/1	Dysphasia, temp >38°C	7	12	MCA, ACA	R/L	Moderate	ICA R/L	2.0	−10	Poor	Unchanged	2	2
16/1	Decreased LOC, disorientation	5	12	Diffuse	R/L	Severe	ICA R/L, VA	3.0	−20	Good	Improved	2	2
17/1	Decreased LOC disorientation	10	24	tICA, MCA, ACA	R	Moderate	ICA R	2.0	0	Good	Improved	1	1
18/1	R/L MCA > 190 cm/s	11	18	tICA, MCA, ACA	L	Moderate	ICA L	2.0	−20	Poor	Unchanged	3	3
19/1	Decreased LOC	10	24	Diffuse	R/L	Severe	ICA R/L VA	5.0	−35	Excellent	Improved	2	2
20/3	Decreased LOC	4	12	tICA, MCA, ACA	L	Moderate	ICA L	2.0	−30	Poor	Unchanged
20^*	Decreased LOC, L MCA > 140 cm/s	5	24	tICA, MCA, ACA	L	Moderate	ICA L	3.0	−25	Poor	Unchanged^*
20^†	Decreased LOC, L MCA > 160 cm/s	6	48	tICA, MCA, ACA	L	Severe	ICA L	3.0	−40	Poor	Improved^†	1	0
21/1	L hemiparesis	8	24	tICA, MCA	R	Moderate	ICA R	3.0	−10	Poor	Improved	2	2
22/1	Decreased LOC	5	12	ACA	R	Severe	ICA R	3.0	−15	Good	Improved	2	2
23/1	Decreased LOC	6	6	tICA, ACA	R	Moderate	ICA R	3.0	−25	Poor	Improved	1	0
24/1	Decreased LOC	10	24	tICA, ACA	L	Moderate	ICA L	2.0	−30	Poor	Unchanged	3	3
25/1	Decreased LOC	5	12	tICA, MCA, ACA	L	Severe	ICA L	3.0	−20	Good	Improved	2	2

Note.—ACA indicates anterior cerebral artery; BA, basilar artery; GOS, Glasgow Outcome Scale (5 indicates death); ICA, internal carotid artery; LOC, level of consciousness; PCA, posterior cerebral artery; SAP, systolic artery pressure; Tx, treatment; and VA, vertebral artery.
* Second treatment.
† Third treatment.